Strong evidence of both benefits and harms for a range of medical indications
Cannabis is used by an estimated 219 million adults globally (4.3% of the population) with a particularly high prevalence in North America (17.4% of the population).1 The 1961 UN Single Convention on Narcotic Drugs included cannabis with opioids and cocaine as a controlled substance whose use was prohibited, but policies have changed considerably in recent decades. Medical use of cannabis is now permitted in large parts of North and South America, Europe, and Oceania; although, patient access varies considerably across jurisdictions. The use of cannabis for non-medical purposes is also now permitted in Canada, 22 US states, and Uruguay, and several other countries are considering allowing adult use in some form (eg, Germany, Luxembourg, Malta, the Netherlands, and Switzerland). In this rapidly changing policy climate, high quality evidence on benefits and risks are needed to inform policy and clinical practi
This strategy involves acknowledging drug consumption as a public health issue rather than relying on what he referred to as an ineffective militarized approach.
The centre-left government of Chancellor Olaf Scholz hopes the law will take profits away from the black market, ensure safety from contamination and reduce drug-related crime.
On Poisons & Policies | Asian Geographic Magazines asiangeo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiangeo.com Daily Mail and Mail on Sunday newspapers.
Ganja Stakeholders Make Recommendations to the Government. westernmirror.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from westernmirror.com Daily Mail and Mail on Sunday newspapers.